Search results
Paper Title International Pharma Congresses during Covid-19
Pharmaceutical congresses and conferences are one of the preferred resources for doctors to learn about new research, treatments and indications . Such congresses in 2020 have become ‘virtual’ in response...Read more
Geraldine Benjamin
English Solicitor, Bailhache Labesse Trustees, UK
GREECE: The claw-back Mechanism
In view of the financial crisis of the recent years, Greece was found forced to settle an agreement with its international creditors, which was sealed by a political memorandum of...Read more

Dimitra Lempesi
Legal Counsel, Sfee, Greece
The Compulsory Licensing in Russia: The First Precedent Lessons Learned
The compulsory license mechanism in Russia had been described in the Civil Code of the Russian Federation for a long time. However, there had been no real cases of granting...Read more

Elvira Dubovskaya
Fulbright Scholar, N/A, Russia
Legal In-house Digitization/Financial Services 
Many factors are changing legal services as we know them. We are seeing the internal and external environment changing the banking model and business needs. Increased regulatory requirements, the evolving...Read more

Andreas Weber
Head Cross-border Legal, Emerging Markets and Change-the Bank, UBS, Ubs , Switzerland
Creating Efficiencies in Drug Discovery and Development Using Artificial Intelligence
The recent growth of machine learning applications using artificial intelligence (AI), ranging from drug discovery to improvements in patient care, has coincided with increased investments from pharmaceutical and technology companies....Read more

Priya Mannan
Associate General Counsel, Novartis Institutes for Biomedical Research, USA
Making it Stick: How to Provide Legal Advice that Influences Business Decisions

As attorneys, determining the most risk-averse legal advice to give to our business partners often comes naturally. After all, we have both academic and professional experience in considering legal questions.
But...Read more

Joshua Axelrod
Brand Counsel, Celgene Corporation, USA
Client Centricity & the In-House Lawyer 
The practice of law has evolved, particularly given the advent of significant technological advances, enhancements, and the evolving nature of the business world. Twenty years ago, first year law students’...Read more

Kari Loeser
Senior Counsel, Jazz Pharmaceuticals , USA
A Glance at Some of the Challenges of the GC Role in Pharma
In the heavily regulated environment in which pharmaceutical companies operate, success is defined by ensuring corporate compliance with disparate laws and regulations without fettering the creativity and innovation on which...Read more

Galit Gonen
Senior Vice President & General Counsel for Teva Europe, Teva Pharmaceuticals, UK
Navigating the Headwaters of Intellectual Property Risk in
the Pharmaceutical Industry

Intellectual property litigation may feel like familiar ground to many competitors in the pharmaceutical drug, medical device, nutraceutical, and other prescription markets. Yet intellectual property laws frequently interact in ways...Read more

Simon Jenner
General Partner, Baker Jenner, USA
The Evolution of In-house Legal & IP Departments
It is not the strongest of the species that survives, nor the most intelligent. It is the one that is most adaptable to change. This quote, likely incorrectly attributed to...Read more

Michael Kock
Head IP, Syngenta International AG, Switzerland